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ABSTRACT
Background: Despite growing support for the distinction between posttraumatic stress 
disorder (PTSD) and complex PTSD (CPTSD) as separate diagnoses within the ICD-11 
psychiatric taxonomy, the prevalence and treatment implications of CPTSD among current 
and ex-serving military members have not been established.
Objective: The study aims were to a) establish the prevalence of provisional ICD-11 CPTSD 
diagnosis relative to PTSD in an Australian sample of treatment-seeking current and ex- 
serving military members, and b) examine the implications of CPTSD diagnosis for intake 
profile and treatment response.
Methods: The study analysed data collected routinely from Australian-accredited treatment 
programmes for military-related PTSD. Participants were 480 current and ex-serving military 
members in this programmes who received a provisional ICD-11 diagnosis of PTSD or CPTSD 
at intake using proxy measures. Measures of PTSD symptoms, disturbances in self- 
organisation, psychological distress, mental health and social relationships were considered 
at treatment intake, discharge, and 3-month follow-up.
Results: Among participants with a provisional ICD-11 diagnosis, 78.2% were classified as 
having CPTSD, while 21.8% were classified as having PTSD. When compared to ICD-11 PTSD, 
participants with CPTSD reported greater symptom severity and psychological distress at intake, 
and lower scores on relationship and mental health dimensions of the quality of life measure. 
These relative differences persisted at each post-treatment assessment. Decreases in PTSD 
symptoms between intake and discharge were similar across PTSD (dRM = −0.81) and CPTSD 
(dRM = −0.76) groups, and there were no significant post-treatment differences between groups 
when controlling for initial scores.
Conclusions: CPTSD is common among treatment-seeking current and ex-serving military 
members, and is associated with initially higher levels of psychiatric severity, which persist 
over time. Participants with CPTSD were equally responsive to PTSD treatment; however, the 
tendency for those with CPTSD to remain highly symptomatic post-treatment suggests 
additional treatment components should be considered.
Prevalencia e implicaciones en el tratamiento del Trastorno de Estrés 
Postraumático Complejo según CIE-11 en miembros militares austra-
lianos activos o en retiro en busca de tratamiento
Antecedentes: A pesar del creciente apoyo para la distinción entre trastorno de estrés 
postraumático (TEPT) y trastorno de estrés postraumático complejo (TEPTC) como 
diagnósticos separados dentro de la taxonomía psiquiátrica de la CIE-11, la prevalencia y 
las implicaciones en el tratamiento del TEPTC dentro de miembros militares activos o en 
retiro no han sido establecidas.
Objetivo: Los objetivos del estudio fueron a) establecer la prevalencia de TEPTC provisional 
según CIE-11 en relación al TEPT en una muestra australiana de miembros militares activos o 
en retiro en busca de tratamiento, y b) examinar las implicaciones del diagnóstico de TEPTC 
para el perfil de ingreso y respuesta a tratamiento.
Método: El estudio analizó datos recolectados de forma rutinaria por programas de trata-
miento australianos acreditados para TEPT relacionado a militares. Los participantes fueron 
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• ICD-11 complex PTSD 
(CPTSD) is more prevalent 
than PTSD in current and ex- 
serving military members 
seeking treatment for PTSD. 
• Responses to 
programmatic trauma- 
focused treatment were 
similar across the two 
provisional diagnoses. 
• Participants with CPTSD 
maintained higher symptom 
severity overall post- 
treatment than those with 
PTSD, and further research is 
needed to establish what 
supplementary treatment 
might be appropriate. 
• CPTSD is more prevalent 
than PTSD in treatment- 
seeking current and ex- 
serving military members. 
Participants with CPTSD 
were equally responsive as 
those with PTSD to trauma- 
focused treatment, though 
those with CPTSD 
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480 miembros activos o en retiro ingresados a este programa bajo el diagnóstico provisional 
de TEPT o TEPTC según CIE-11 a través de indicadores indirectos. Al ingreso, egreso y a los 3 
meses de seguimiento, se consideraron mediciones de los síntomas de TEPT, alteraciones en 
la organización del Yo, estrés psicológico, salud mental y relaciones sociales.
Resultados: Dentro de los participantes con un diagnóstico provisional según CIE-11, el 
78,2% fue clasificado como portador de TEPTC, mientras que un 21,8% fue clasificado como 
portador de TEPT. Al ser comparados con TEPT según CIE-11, los participantes con TEPTC 
reportaron al ingreso una mayor severidad en la sintomatología y en el estrés psicológico, y 
menores puntajes en las dimensiones de medida de calidad de vida de salud mental y 
relaciones sociales. Estas diferencias relativas persistieron en cada seguimiento posterior al 
tratamiento. Las disminuciones en los síntomas de TEPT entre el ingreso y el egreso fueron 
similares entre los grupos con TEPT (dRM = -0.81) y TEPTC (dRM = -0.76), y no hubo 
diferencias significativas post-tratamiento entre los grupos al controlarlos según los pun-
tajes iniciales.
Conclusiones: El TEPTC es común dentro de miembros militares activos o en retiro en busca 
de tratamiento, y está asociado a mayores niveles de severidad psiquiátrica inicial, la cual 
persiste a lo largo del tiempo. Los participantes con TEPTC respondieron igualmente al 
tratamiento del TEPT; sin embargo, la tendencia de aquéllos con TEPTC de permanecer 
altamente sintomáticos tras el tratamiento sugiere componentes de tratamiento adicionales 
que deberían ser considerados.
澳大利亚寻求治疗的现役和退役军人中ICD-11 复杂性PTSD 的流行率和 
治疗意义
背景: 尽管在ICD-11精神病学分类法中作为独立诊断的创伤后应激障碍 (PTSD) 和复杂性 
PTSD (CPTSD) 之间的区别得到越来越多的支持, 但现役和退役军人中CPTSD的流行率和治 
疗意义尚未得到证实。
目的: 本研究旨在:a) 在澳大利亚寻求治疗的现役和退役军人样本中, 确定相对于PTSD的 




考虑了治疗期间, 出院时和3个月的随访时的PTSD症状, 自我组织障碍, 心理困扰, 心理健康 
和社会关系的测量。
结果: 在具有ICD-11临时诊断的参与者中, 有78.2%归类为CPTSD组, 而21.8%;归类为PTSD 
组。相较于ICD-11 PTSD组, CPTSD组的参与者在治疗摄入时报告了更高的症状严重程度和 
心理困扰, 和更低的生活质量测量的关系和心理健康维度得分。这些相对差异在每次治疗 
后评估中均持续存在。治疗和出院时PTSD组 (dRM = −0.81) 和CPTSD组 (dRM = −0.76) PTSD 
症状的减少相似, 并且在控制初始得分时治疗后无显著组间差异。
结论: 在寻求治疗的现役和退役军人中CPTSD很常见, 并且与初始更高的精神病严重程度有 
关, 并随着时间的流逝而持续。 患有CPTSD的参与者对PTSD的治疗反应相同。但是, 对于 
CPTSD患者, 在治疗后仍保持高度症状的趋势表明, 应考虑使用额外治疗方法。
maintained higher symptom 
severity pre- and post- 
treatment. 
1. Introduction
The 11th edition of the International Classification of 
Diseases and Related Health Problems (ICD; World 
Health Organisation, 2018) has introduced significant 
changes under the umbrella of ‘disorders specifically 
associated with stress’. Alongside the previously 
established diagnosis of posttraumatic stress disorder 
(PTSD), the new ICD-11 taxonomy has proposed 
a ‘sibling’ diagnosis with a related but distinct symp-
tom profile: complex PTSD (CPTSD). This addition 
was based on mounting evidence, extending on the 
work of Herman (1992) and earlier researchers (De 
Wind, 1972; Horowitz, 1974; Marmar, 1991; 
Niederland, 1964), highlighting the impact of pro-
longed and/or repetitive interpersonal traumatic 
stress on self-organisation independently of PTSD 
symptomatology.
According to the ICD-11, the CPTSD diagnostic 
concept retains the core symptom clusters of PTSD 
including: (1) re-experiencing the traumatic event in 
the form of flashbacks or nightmares; (2) avoidance of 
internal and external trauma reminders related to the 
event; and (3) persistent-heightened sense of current 
threat, indicated by hypervigilance or increased startle 
response (World Health Organisation, 2018). However, 
CPTSD is also characterised by additional symptoms 
relating to ‘disturbances in self-organisation’ (DSO), 
which comprise three clusters relating to negative self- 
concept (e.g. feelings like failure or worthlessness), 
affective dysregulation (e.g. heightened or lowered 
emotional reactivity), and disturbances in relationships 
(e.g. difficulties in establishing or sustaining interperso-
nal connections, or avoidance of relationships; 
Maercker et al., 2013). In order to meet a CPTSD diag-
nosis, each of the PTSD diagnostic criteria must be met, 
as well as at least one symptom from each of the three 
DSO clusters (Cloitre, Garvert, Brewin, Bryant, & 
Maercker, 2013). Notably, those with a CPTSD diagno-
sis are not considered to have a PTSD diagnosis, such 
that a PTSD diagnosis and a CPTSD diagnosis are 
mutually exclusive.
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The Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5; American Psychiatric Association, 
2013) has taken a different approach than ICD-11 to 
address clinical complexity in PTSD conditions. 
Rather than introducing a new diagnosis, the DSM- 
5 expanded the prior DSM-IV PTSD diagnostic cri-
teria to include ‘negative alterations in cognitions and 
mood’, which overlaps significantly with complex 
PTSD-associated negative self-concept, affective dys-
regulation, and difficulties in relationships. In addi-
tion, the expanded DSM-5 criteria include a specifier 
for a dissociative subtype, with dissociation more 
commonly associated with complex presentations. 
As such, these two nosological systems differ regard-
ing whether or not complex PTSD constitutes 
a distinct diagnostic category. The ICD-11 PTSD 
diagnosis has aimed to be more specific in identifying 
PTSD, with relevant studies also demonstrating that 
ICD-11 PTSD prevalence estimates are lower than 
those derived from the DSM-5 (Wisco et al., 2016).
There is considerable empirical support for dis-
tinct profiles of ICD-11 PTSD and CPTSD sympto-
matology, suggesting that CPTSD is a useful addition 
to this psychiatric taxonomy. Given that the ICD-11 
took a restricted approach to the PTSD diagnosis by 
only including core intrusion, avoidance, and arousal 
symptoms that are specific to PTSD and not shared 
by other disorders (Brewin et al., 2017), the CPTSD 
diagnosis provides a way of distinguishing those with 
more complex presentations. CPTSD has been differ-
entiated from PTSD in a broad range of trauma- 
exposed samples, including victims of childhood 
interpersonal trauma (e.g. repeated childhood physi-
cal or sexual abuse (Cloitre, Garvert, Weiss, Carlson, 
& Bryant, 2014) or maltreatment within institutional 
settings (Knefel, Garvert, Cloitre, & Lueger-Schuster, 
2015), as well as adults exposed to terrorism (Cloitre 
et al., 2013), prisoners of war (Palic et al., 2016; 
Zerach, Shevlin, Cloitre, & Solomon, 2019), refugees 
(Hyland et al., 2018; Nickerson et al., 2016; Palic 
et al., 2016) and homeless populations (Armstrong, 
Phillips, Alkemade, & Louise O’Donnell, 2020). 
However, empirical research into how the CPTSD 
concept might apply to military populations is both 
scarce and inconsistent. While Palic et al. (2016), 
Folke, Nielsen, Andersen, Karatzias, and Karstoft 
(2019), and Mordeno, Nalipay, and Mordeno (2019) 
have identified distinct CPTSD symptom profiles in 
military samples, Wolf et al. (2015) question the 
validity of the CPTSD diagnosis, arguing that PTSD 
and CPTSD are not distinct. The degree to which the 
CPTSD diagnosis has utility in the context of mili-
tary-related trauma thus requires further exploration.
Research into the prevalence of CPTSD as defined 
by ICD-11 criteria is now emerging. Early estimates 
of ICD-11 CPTSD in general population samples 
have suggested rates ranging from 0.5% to 2.6%, 
relative to 2.3% to 9.0% for ICD-11 PTSD (Ben- 
Ezra et al., 2018; Hyland et al., 2017; Maercker, 
Hecker, Augsburger, & Kliem, 2018; Wolf et al., 
2015). Sample-based estimates for specific subpopu-
lations have also indicated rates of ICD-11 CPTSD 
ranging from 13% to 20.7% among victims of single 
event physical and sexual assault, respectively (Elklit, 
Hyland, & Shevlin, 2014), 21.4% among survivors of 
childhood institutional abuse (Knefel & Lueger- 
Schuster, 2013), 32.8% among refugees (Nickerson 
et al., 2016), and 42.8% among survivors of childhood 
sexual abuse (Hyland et al., 2017). In the first studies 
of CPTSD in veterans, Wolf et al. (2015) found 
a CPTSD prevalence rate of 13% and PTSD preva-
lence rate of 21.4% in an internet-based sample of 
trauma-exposed military veterans from the U.S., 
while Mordeno et al. (2019) found prevalence rates 
of 16.4% CPTSD and 36.7% PTSD in Filipino com-
bat-exposed soldiers. Conversely, in a latent profile 
analysis of a sample of treatment-seeking Danish 
military veterans, Folke et al. (2019) found that 
14.1% scored highly on only PTSD symptoms, 
whereas 17.3% scored highly on PTSD as well as 
DSO symptoms. Furthermore, a recent study found 
that 80.63% of treatment-seeking Croatian military 
veterans with a prior PTSD diagnosis met criteria 
for a provisional CPTSD diagnosis (Letica-Crepulja 
et al., 2020). It should be noted that with the excep-
tion of Letica-Crepulja et al. (2020), these papers used 
proxy measures of ICD-11 PTSD and DSO symp-
toms – i.e. items taken from other measures that 
map onto ICD-11 symptoms – rather than ICD-11- 
based clinician-administered measure. Nonetheless, 
these high prevalence rates of CPTSD amongst veter-
ans, and their variability relative to PTSD rates, sug-
gest that it is important to continue investigations 
into the clinical utility of the ICD-11 CPTSD diag-
nosis in this population.
In order to determine the utility of the CPTSD 
diagnosis among current and ex-serving military 
members, the potential implications of the CPTSD 
classification for treatment response should be 
investigated. There has been vigorous debate as to 
whether individuals with CPTSD are likely to benefit 
from modified forms of current evidence-based 
PTSD treatments; specifically, whether those with 
CPTSD require interventions that directly address 
problems in emotion regulation, negative self- 
concept and disturbances in relationships (Cloitre, 
2015; De Jongh et al., 2016; Karatzias & Cloitre, 
2019). The recommendation for additional CPTSD- 
specific intervention is predicated on the idea that 
standard trauma-focused treatment may be less 
effective for those with CPTSD – however, others 
have argued that there is insufficient evidence to 
support this (De Jongh et al., 2016). While treatment 
guidelines support the efficacy of trauma-focused 
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interventions for PTSD more broadly (Hamblen 
et al., 2019; International Society of Traumatic 
Stress Studies, 2018b; National Institute for Health 
and Care Excellence, 2018; Phoenix Australia Centre 
for Posttraumatic Mental Health, 2013), there are 
limited data available regarding their efficacy speci-
fically for treating CPTSD. However, one meta- 
analysis of 51 PTSD treatment trials found beneficial 
effects of trauma-focused treatments, such as cogni-
tive behavioural therapy (CBT), exposure alone (EA) 
and eye movement desensitisation and reprocessing 
(EMDR), in reducing PTSD symptoms in those 
likely to have clinically significant baseline levels of 
one or more DSO symptom cluster; albeit with 
smaller effects than non-specific interventions 
(Karatzias et al., 2019). This review also indicated 
that standard CBT and EA reduced the distinctive 
CPTSD symptoms, specifically negative self-concept 
and relationship disturbances. There was, however, 
insufficient evidence regarding the treatments’ 
impacts on emotion dysregulation. Such studies sug-
gest that standard trauma-focused interventions may 
be effective not only for patients with PTSD, but also 
for those with CPTSD. In Australia, standard 
trauma-related interventions focussed on PTSD, 
not CPTSD, are commonly provided to treatment- 
seeking current and ex-serving military members – 
however, it remains unclear to what extent this 
standard treatment might also benefit those with 
CPTSD.
1.1. Aims
This study involved the investigation of treatment 
outcome data collected routinely from Australian 
current and ex-serving military members seeking 
PTSD treatment, and was intended to address the 
following aims:
Aim I: Establish the relative rates and socio- 
demographic, service-related and pension-related 
characteristics of ICD-11 PTSD and CPTSD presen-
tations in a sample of current and ex-serving military 
members seeking treatment for PTSD; and 
Aim II: Examine the extent to which a provisional 
CPTSD diagnosis is associated with distinct treat-
ment intake profiles and treatment response patterns 
in a national accredited PTSD treatment pro-
grammes for current and ex-serving military mem-
bers with PTSD. 
2. Method
2.1. Participants and procedure
Participants comprised current and ex-serving mem-
bers of the Australian Defence Force (ADF) who 
participated in one of 14 accredited PTSD treatment 
programmes across Australia that were funded by the 
Australian Government Department of Veterans’ 
Affairs (DVA) between 2014 and 2019. Participants 
are referred to the programmes by their GPs, treating 
psychiatrists or psychologists, and ex-serving mem-
bers typically have not responded to prior treatment 
and/or have long chronicity of disorder. In order to 
be eligible for treatment, participants were required 
to meet diagnostic criteria for military-related PTSD 
on the Clinician Administered PTSD Scale for DSM- 
5 (Weathers et al., 2018). Routine treatment in these 
accredited PTSD treatment programmes followed 
national DVA accreditation standards for group and 
individual intervention components (Department of 
Veterans’ Affairs, 2015). The individual components 
specified in these standards include engagement 
work, evidence-based trauma-focussed therapy and 
relapse prevention. The group components include 
psychoeducation and symptom management, includ-
ing for comorbid problems such as anxiety, anger, 
depression, sleep and substance use issues. 
Programmes incorporated 20–30 treatment days 
with each cohort of 5–10 participants receiving 
a combination of individual and group therapy. 
Participants were excluded from the programmes if 
they were currently psychotic, actively suicidal, had 
acute substance use disorders or were currently 
experiencing major life crises. As part of the pro-
grammes quality assurance processes, all 
participants completed a battery of standardised 
questionnaires at treatment intake, and again at treat-
ment discharge and 3 months post-treatment follow- 
up. The Australian Government Departments of 
Defence and Veterans’ Affairs Human Research 
Ethics Committee approved the administration of 
these questionnaires and secondary analyses of these 
for research purposes.
As the present study aimed to investigate the pre-
valence and treatment implications of the ICD-11 
CPTSD concept in a military sample, eligibility for 
inclusion of a participant’s data in the analysis 
required a provisional ICD-11 diagnosis of either 
PTSD or CPTSD. Figure 1 presents the total number 
of current and ex-serving members of the ADF who 
had commenced the programmes with a DSM-5 
PTSD diagnosis (n = 780), those excluded from the 
original data source, and the final number of partici-
pants included in this study (n = 458).
2.2. Measures
2.2.1. Sociodemographic variables
A variety of sociodemographic information was 
collected at treatment intake, including participant 
age, gender, marital status, employment status, ser-
vice status, and pension status, and whether 
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participants were applying for a pension or 
a pension increase.
2.2.2. PTSD symptoms
PTSD symptom severity was measured using the 
PTSD Checklist (PCL-5), which is a 20-item self- 
report scale that measures DSM-5 PTSD symptoms 
in the past month (Blevins, Weathers, Davis, Witte, 
& Domino, 2015). Items ask respondents to rate 
the degree to which they were bothered by symp-
toms using 5-point scales ranging from ‘not at all’ 
(0) to ‘extremely’ (4). The PCL-5 has demonstrated 
good internal consistency, convergent and discrimi-
nant validity, and strong structural validity based 
on confirmatory factor analysis (Blevins et al., 
2015). Participants were asked to answer PCL-5 
items with reference to their most traumatic mili-
tary experience.
A provisional diagnosis of ICD-11 PTSD was made if 
participants reported a score of 2 (‘moderately’) or 
higher on at least one of the two items measuring re- 
experiencing (PCL-5 item 2 and 3), avoidance (PCL-5 
item 6 and 7), and sense of threat (PCL-5 items 17 and 
18), and did not exhibit significant DSO features (see 
Figure 1. Flow chart depicting inclusion and exclusion of participants for analyses.
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below). This subset of PCL-5 items was used to make 
a provisional ICD-11 PTSD diagnosis as they best relate 
to the core ICD-11 PTSD criteria, i.e. re-experiencing, 
avoidance and heightened sense of threat (see Barbano 
et al., 2019; Cloitre et al., 2018).
2.2.3. Disturbance in Self-Organisation (DSO)
DSO symptoms were measured using a preliminary 
version of the DSO subscale of the International 
Trauma Questionnaire (ITQ; Cloitre et al., 2018). This 
preliminary version (Cloitre, Roberts, Bisson, & Brewin, 
2014) was provided by the ITQ authors in advance of its 
publication, and the final published version of the scale 
is a subset of the DSO items provided in the draft 
measure – only the items included in the final measure 
were included for analysis in this study. This subscale 
measure comprises six items, with two items each mea-
suring affective dysregulation, negative self-concept and 
disturbances in relationships, as well as three linked 
items addressing functional impairment. See Table 1 
for a full list of scale items. Item responses are scored 
on a 5-point scale ranging from ‘not at all’ (0) to 
‘extremely’ (4), and preliminary research indicates the 
6-item scale has good structural validity and favourable 
psychometric properties (Cloitre et al., 2018; Shevlin 
et al., 2018). There is early evidence for the validity of 
the ITQ and its ability to distinguish between PTSD and 
CPTSD within veteran populations (Murphy et al., 
2020). It should be noted that the PTSD items of the 
ITQ were not provided in advance – as such, the rele-
vant items on the PCL-5 were used to measure PTSD 
symptoms instead.
A provisional diagnosis of CPTSD was made if 
participants met criteria for ICD-11 PTSD using the 
subset of PCL-5 items and also met criteria for DSO 
symptom clusters according to the subscale measure 
of the ITQ. Consistent with the approach used in 
the ITQ validation study (Cloitre et al., 2018), 
a positive DSO screen required that participants 
report scores of 2 (‘moderately’) or higher on at 
least one of the two items assessing each DSO 
symptom feature (affective dysregulation, negative 
self-concept, disturbances in relationships), and at 
least one of the three items assessing functional 
impairment. Supplementary analyses investigating 
the impact of treatment specifically on DSO symp-
toms used the sum of each individual’s scores across 
all six DSO-related items, where potential scores 
could range from 0 to 24.
2.2.4. Psychological distress
The Kessler Psychological Distress Scale (K10; Kessler 
et al., 2002) comprises 10 items assessing general 
psychological distress, which are scored on a 5-point 
scale ranging from ‘None of the time’ (1) to ‘All of 
the time’ (5). Items are summed to produce a total 
score, where the maximum score of 50 indicates 
severe distress and the minimum of 10 indicates no 
distress. The K10 has shown high levels of internal 
consistency and concurrent validity (Hides et al., 
2007), and internal reliability in this sample was 
calculated at intake as α = .90.
2.2.5. Quality of life
Quality of life was assessed using the ‘Relationships’ and 
‘Mental Health’ subscales of the Assessment of Quality of 
Life Questionnaire – 4D (AQOL-4D; Hawthorne, 
Richardson, & Osborne, 1999), which consist of 3 items 
each. These subscales were chosen for this study as they 
were expected to be most sensitive to symptom change, 
whereas the ‘Senses’ and ‘Independent Living’ subscales 
were not included as they were not considered concep-
tually relevant, and no changes were expected as a result of 
treatment or PTSD symptom exacerbation. Each item is 
scored on a scale ranging from 1 to either 4 or 5, and 
a total score for each scale is produced from summing 
item scores within that domain. Higher scores on the 
AQOL signify poorer quality of life. The AQOL-4D has 
excellent psychometric properties and high levels of con-
struct validity (Hawthorne, Richardson, & Day, 2001). 
Mean inter-item correlations were used to index item 
homogeneity for these subscales since Cronbach’s alpha 
is biased with small numbers of items. Values above .20 
indicate acceptable levels of homogeneity (Briggs & 
Cheek, 1986). Both the Mental Health (Mean r = .35) 
and Relationships (Mean r = .21) subscales displayed 
acceptable properties in this sample at treatment intake.
2.2.6. Anxiety and depressive symptoms
The Hospital Depression and Anxiety Scale (HADS; 
Zigmond & Snaith, 1983) comprises 14 items, 
which form two subscales of seven items each, 
assessing anxiety and depressive symptoms, respec-
tively. For each question, participants indicate the 
reply that is closest to how they have felt in the 
past week. Items are rated on a scale from 0 to 3, 





How true is this of you?




2. I feel numb or emotionally shut down.
3. I feel like a failure. Negative self- 
concept4. I feel worthless.
5. I feel distant or cut-off from people. Disturbances in 
relationships6. I find it hard to stay emotionally close to 
people.
In the past month, have the above problems in emotions, in beliefs about 
yourself and in relationships:
1. Created concern or distress about your 
relationships or social life?
Functional 
impairment
2. Affected your work or ability to work?
3. Affected any other important parts of your 
life such as parenting, or school or college 
work, or other important activities?
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and form a score of 0–21 for each subscale. The 
HADS has demonstrated high concurrent validity 
and internal reliability (Bjelland, Dahl, Haug, & 
Neckelmann, 2002). Internal reliability was calcu-
lated as α = .80 for the anxiety subscale and α = .74 
for the depression subscale.
2.3. Data analysis
Data-file preparation and preliminary analyses were 
conducted using SPSS Version 25, while subsequent 
analyses used Program R 3.5.1 and MPlus Version 8. 
Preliminary analyses involved screening for out of 
range values and description of missing data. This 
included examination of any systematic patterns of 
missing data over time, through a series of logistic 
regression analyses which quantified associations with 
loss to follow-up and treatment intake measures of age, 
ex-serving (versus currently serving), marital and 
employment status, as well as PTSD symptom severity.
Descriptive statistics (frequencies and proportions) 
were initially produced for purposes of addressing Aim 
I, while χ2 tests were used to explore associations with 
CPTSD and various socio-demographic and service- 
related characteristics. In order to examine Aim II, parti-
cipants who received a classification of CPTSD were 
considered relative to participants with a provisional 
diagnosis of ICD-11 PTSD. For these groups, descriptive 
statistics (Means and SDs) were produced at treatment 
intake, treatment discharge and 3-month post-treatment 
follow-up, across primary outcome measures including 
the PCL-5, K10, and the Relationships and Mental 
Health subscales of the AQOL-4D, and secondary out-
come measure, the HADS (depression and anxiety sub-
scales). Inferential tests of between-group differences 
were conducted at each time point, and comprised inde-
pendent group t-tests. A series of repeated measures 
effect size estimates (dRM) with 95% Confidence 
Intervals (CIs) were then used to quantify the overall 
magnitude of change for each group over time, and 
also to inform between-group comparisons in the mag-
nitude of change. These effect size estimates were analo-
gous to Cohen’s d statistic, but were based on formulae 
for the single-group pre-test-post-test design which stan-
dardises the sample mean change by variability in change 
scores (as opposed to the pooled between-group varia-
bility) (Morris & DeShon, 2002). These were produced in 
Program R using the Package ‘effsize’ (Torchiano, 2016).
The aforementioned analyses all used pairwise 
deletion of missing data from loss to follow-up, and 
further analyses were then conducted using Multiple 
Imputation (MI) of missing values (across k = 20 
data sets). The latter were conducted in MPlus ver-
sion 8, which was also used to specify a series of 
linear regression models with imputed datasets in 
which outcome measures at discharge and 3-month 
post-treatment were considered as endogenous 
variables in separate analyses. These were estimated 
using robust Maximum Likelihood (MLR) estima-
tion, and also specified exogenous variables includ-
ing intake measures of the outcome variable, and 
a binary variable indicating CPTSD status. These 
analyses thus compared CPTSD with ICD-11 PTSD 
on each outcome measure (i.e. PCL-5, K10, and 
Relationships and Mental Health subscales of the 
AQOL-4D), and were equivalent to Analysis of 
Covariance (ANCOVA) models controlling for 
scores at intake.
Finally, there were a series of supplementary ana-
lyses conducted in order to examine the nature and 
extent of change in DSO symptoms among participants 
with CPTSD. For purposes of these exploratory ana-
lyses, a summed scale score based on the six DSO items 
were derived at each time-point, and were treated as an 
indicator of DSO symptom severity. Descriptive statis-
tics and repeated measures effect size estimates (dRM) 
were then produced for this measure in order to quan-
tify the magnitude of change in DSO symptoms for the 
CPTSD group over time.
3. Results
3.1. Missing data analyses
A series of logistic regression analyses were con-
ducted to examine bivariate associations between 
loss to follow-up and treatment intake measures of 
age, ex-service (versus currently serving), marital and 
employment status, as well as PTSD symptom sever-
ity. These indicated no significant (p < .05) differ-
ences between participants who completed and were 
lost to follow-up at treatment discharge. However, 
higher PTSD scores at treatment intake were asso-
ciated with an increased likelihood of being lost to 
follow-up at 3 months post-treatment (OR = 1.02), 
while older age was associated with a decreased like-
lihood of loss to follow-up at 3 months (OR = .97). 
These point estimates for the OR were small in mag-
nitude and thus suggested that any potential biases 
from systematic patterns of missing data were 
modest.
3.2. Descriptive analyses
Within the current sample of participants with 
a provisional ICD-11 diagnosis, 21.8% (n = 100) 
were classified as having ICD-PTSD, and 78.2% 
(n = 358) were classified as CPTSD. Table 2 presents 
descriptive and χ2 analyses of associations with pro-
visional CPTSD (versus ICD-PTSD) across a range 
of sociodemographic and service-related character-
istics. As can be seen, there were no significant 
differences across participants with CPTSD versus 
ICD-PTSD according to gender, employment and 
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service status, or any pension-related characteristic. 
However, there was a significant association 
observed with marital status, indicating that partici-
pants with CPTSD were less likely to be in a marital/ 
de facto relationship (Partnered: 66.5%) when com-
pared to participants with ICD-PTSD (77.0%). 
Participants with a provisional CPTSD diagnosis 
also had more severe anxiety and depressive symp-
toms, as measured by the HADS at intake, when 
compared to those with ICD-PTSD.
3.3. Implications of CPTSD for treatment 
outcomes
Table 3 shows descriptive statistics across all outcome 
measures for participants with ICD-11 CPTSD versus 
PTSD. At treatment intake, participants with CPTSD, 
relative to ICD-PTSD, exhibited significantly higher levels 
of PTSD symptom severity (as measured by the PCL-5), 
depressive and anxious symptom severity (as measured by 
the HADS), psychological distress (as measured by the 
Table 3. Outcome measures for ICD-PTSD and CPTSD groups across intake, discharge and 3-month follow-up.
Descriptive Statistics dRM Effect Size Estimates
Intakea Dischargea 3-month follow-upa Intake to Discharge Discharge to 3-months follow-up




LB UB LB UB
CPTSD (n = 358)
PCL-5 358 60.4 9.0 294 49.6 15.4 231 47.0 16.1 −0.76 −0.92 −0.59 −0.18 −0.36 0.01
K10 357 37.1 5.9 292 31.7 8.6 231 31.2 8.8 −0.64 −0.80 −0.47 −0.06 −0.25 0.12
HADS Anxiety 358 15.3 3.0 296 12.8 3.9 233 12.5 3.8 −0.65 −0.77 −0.52 −0.09 −0.19 0.01
HADS Depression 358 13.3 3.3 296 11.0 3.9 233 10.8 4.3 −0.63 −0.75 −0.50 −0.02 −0.12 0.09
AQOL-4D relationships 347 8.5 1.9 292 8.0 1.9 229 7.7 2.0 −0.22 −0.38 −0.05 −0.13 −0.31 0.06
AQOL-4D mental health 348 9.0 1.5 293 8.5 1.7 228 8.3 1.6 −0.33 −0.49 −0.16 −0.05 −0.24 0.13
ICD-PTSD (n = 100)
PCL-5 99 49.7 8.6 84 38.0 15.5 68 37.9 16.9 −0.81 −1.13 −0.49 −0.04 −0.39 0.30
K10 100 27.4 6.2 83 24.6 7.3 68 24.3 7.9 −0.44 −0.75 −0.13 0.03 −0.32 0.37
HADS Anxiety 100 12.3 3.4 84 10.3 3.9 68 10.3 4.1 −0.52 −0.73 −0.33 0.03 −0.14 0.19
HADS Depression 100 10.5 3.2 84 8.7 3.7 68 9.0 3.7 −0.54 −0.75 −0.33 0.13 −0.05 0.32
AQOL-4D relationships 97 7.2 1.8 81 7.0 1.6 66 6.9 1.5 −0.14 −0.45 0.17 0.11 −0.24 0.46
AQOL-4D mental health 98 8.0 1.5 83 7.8 1.7 66 7.5 1.5 −0.20 −0.51 0.11 −0.14 −0.49 0.21
aAll between-group differences (CPTSD versus ICD-PTSD) at each time-point and across measures were significant at p < 0.01 level. 
bEffect size estimate (dRM) presented in bold indicate effects that were significantly different from zero (95% CIs do not include zero). 
Table 2. Sociodemographics of ICD-PTSD and CPTSD subgroups in a treatment-seeking sample 





Group comparisonsn % n %
Gender
Male 97 97.0 327 91.3 χ2 (1) = 3.70, p = .24
Female 3 3.0 30 8.4
Marital status
Partnered 77 77.0 238 66.5 χ2 (1) = 4.67, p = .04
Not Partnered 21 21.0 116 32.4
Employment status
Working 24 24.0 64 17.9 χ2 (1) = 1.72, p = .24












χ2 (1) = 2.18, p = .19
Pension Status
Pensioned 79 79.0 303 84.6 χ2 (1) = 4.63, p = .24
No Pension 9 9.0 29 8.1
Pension Increase
No 36 36.0 123 34.4 χ2 (1) = .67, p = .45
Yes 49 49.0 205 57.3
Pension Application
No 40 40.0 143 39.9 χ2 (1) = .26, p = .63
Yes 47 47.0 190 53.1
M SD M SD Group comparisons
HADS Anxiety 12.3 3.4 15.3 2.96 t(456) = 8.49, p < .01
HADS Depression 10.5 3.2 13.3 3.3 t(456) = 7.58, p < .01
Percentages may not always sum to 100% due to missing data. 
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K10), and lower quality of life (as measured by the 
Relationships and Mental Health subscales of the 
AQOL-4D). Furthermore, the CPTSD group continued 
to report higher PTSD severity, depressive and anxious 
symptom severity, and psychological distress, and 
lower levels of quality of life, at both treatment dis-
charge and 3-month follow-up. Table 3 also presents 
estimates of repeated measure effect size (dRM), along 
with 95% CIs, which quantify the magnitude of 
change for both the CPTSD and ICD-PTSD groups 
over time. As can be seen, the CPTSD group reported 
levels of change over time across outcomes that were 
broadly comparable to changes for participants with 
ICD-PTSD. By way of illustration, the point estimate 
for dRM indicated substantial reductions in PCL-5 
scores for the CPTSD group between intake and 
discharge (dRM = −0.76), which were similar to 
changes observed for participants with ICD-PTSD 
(dRM = −0.81). Both groups then indicated no discern-
ible change between treatment discharge and 3-month 
follow-up. These approximately parallel changes were 
notwithstanding that the CPTSD group had signifi-
cantly higher scores initially, and thus also had higher 
scores at each post-treatment assessment (i.e. discharge 
and 3 months follow up; see Figure 2). A similar pattern 
of change was observed for secondary outcome mea-
sures of anxiety and depression symptoms; point esti-
mates for DRM indicated reductions in HADS scores 
for the CPTSD group between intake and discharge 
(dRM-depression = −0.63, dRM-anxiety = −0.65) which 
paralleled changes observed for participants in the ICD- 
PTSD group (dRM-depression = −0.54, dRM-anxiety = −0.52). 
No discernible change between treatment discharge and 
3 months follow-up were observed for either group. 
Changes in psychological distress between intake and 
discharge were also comparable across CPTSD 
(dRM = −0.64) and ICD-PTSD groups (dRM = −0.44), 
while there were low levels of change across time for 
both groups when defined by AQOL-4D subscales. 
Results from follow-up regression analyses (see Table 
4) also indicated no significant effects, and thus no 
discernible differences in treatment response between 
the ICD-PTSD and CPTSD groups across the primary 
outcome measures when adjusting for higher levels of 
intake severity associated with CPTSD.
Using the criteria for provisional diagnosis defined in 
the ITQ validation study (Cloitre et al., 2018), we also 
examined loss of diagnosis between intake and discharge. 
Amongst those with a provisional ICD-11 CPTSD diag-
nosis at intake (n = 358), 50.6% (n = 181) retained this 
diagnosis at discharge, 12% (n = 43) moved to a provi-
sional PTSD diagnosis at discharge, while 37.4% (n = 134) 
did not report either diagnoses. Comparatively, amongst 
participants with a provisional ICD-PTSD diagnosis at 
intake (n = 100), 27% (n = 27) retained this provisional 
diagnosis at discharge, while 16% (n = 16) moved to 
a provisional diagnosis of CPTSD, and 57% (n = 57) did 
not report either diagnosis.
Finally, a supplementary series of analyses were 
conducted to examine the nature of change in DSO 
symptoms for participants classified in terms of 
CPTSD. A summed scale score based on the six 
Figure 2. Course of symptom severity at intake, discharge and 3 months post-treatment for (A). PCL-5 score severity for ICD-11 
PTSD and CPTSD groups and (B). Average total DSO score severity for CPTSD group.
Table 4. Treatment effects for ICD-PTSD and CPTSD groups across primary outcome measures when adjusting for scores at 
treatment intake.
PCL K10 AQOL-4D Relationships AQOL-4D Mental Health
β SE p β SE p β SE p β SE p
Discharge
CPTSD - - - - - - - - - - - -
ICD-11 PTSD −0.08 0.05 0.068 −0.03 0.04 0.448 −0.06 0.04 0.093 −0.04 0.04 0.326
3-month follow-up
CPTSD - - - - - - - - - - - -
ICD-11 PTSD −0.05 0.05 0.308 −0.02 0.04 0.714 −0.01 0.04 0.895 −0.07 0.04 0.086
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DSO items (where potential scores could range 
between 0 and 24) was derived and treated as an 
indicator of DSO symptom severity at intake 
(M = 18.9, SD = 3.4), treatment discharge 
(M = 15.1, SD = 5.8) and 3-month post-treatment 
follow-up (M = 14.4, SD = 6.1). Repeated measures 
effect size estimates were produced and indicated 
moderate-large reductions in DSO symptom severity 
from intake to discharge (dRM = −0.70, 95% 
CI = −0.87 to −0.54), which were maintained with 
no additional changes from discharge to 3-month 
follow-up (dRM = −0.07, 95% CI = −0.26 to 0.11).
4. Discussion
The aim of this study was to investigate the relative 
rates and treatment implications of a CPTSD diag-
nosis in a treatment-seeking sample of Australian 
current and ex-serving military members with 
a provisional ICD-11 PTSD or CPTSD diagnosis. 
The results indicated that over 75% of this sample 
met provisional criteria for CPTSD, demonstrating 
not only a high rate of CPTSD, but also that 
CPTSD is a more common disorder than ICD-11 
PTSD among this group of current and ex-serving 
military members seeking PTSD treatment.
The findings of this study are in contrast to those 
of Wolf et al. (2015), who found that ICD-11 PTSD 
was more prevalent in veterans than CPTSD. This 
discrepancy may be due to differences across target 
populations for each of these studies, with Wolf 
et al.’s sample being non-treatment-seeking veterans, 
unlike those in the present study. However, the cur-
rent results are consistent with Letica-Crepulja et al. 
(2020)’s findings that around 80% of treatment- 
seeking military veterans met criteria for a probable 
diagnosis of CPTSD, as well as Folke et al. (2019)’s 
latent profile analysis which found that treatment- 
seeking veterans were more often in the CPTSD 
symptom class than the PTSD symptom class. It 
may be that while PTSD is comparatively more pre-
valent among the general population of veterans, 
the symptom composition that characterise CPTSD 
may drive treatment-seeking and may thus be the 
predominant diagnosis for veterans who present to 
trauma-related clinical services. This is consistent 
with evidence from other trauma-exposed popula-
tions which also suggests higher CPTSD rates 
among clinical samples when compared to commu-
nity samples (Brewin et al., 2017).
The results also indicated that participants with 
CPTSD, when compared to ICD-11 PTSD, reported 
higher PTSD symptom severity, psychological dis-
tress, and anxiety and depressive symptoms, as well 
as lower levels of relationship and mental health 
dimensions of quality of life, and these relative 
differences persisted at each post-treatment assess-
ment. Such findings suggest that in this clinical con-
text, the CPTSD diagnosis is capturing participants 
with both more severe symptoms, as well as more 
severe impacts in other areas of life (e.g. relation-
ships), associated with DSO symptoms (Karatzias 
et al., 2017).
The current study also found that participant 
responses to Australian DVA-funded accredited 
PTSD treatment programmes did not differ sig-
nificantly between participants who had 
a provisional diagnosis of ICD-11 PTSD and 
those who had CPTSD. Rather, participants in 
both diagnostic categories showed significant and 
large reductions in PTSD symptomatology and 
general psychological distress from intake to dis-
charge. Although participants in the CPTSD 
group displayed higher psychiatric severity across 
all measures at both intake and discharge, relative 
to ICD-11 PTSD, there were no discernible differ-
ences in the rate of change across time in PTSD 
severity, quality of life, or general psychological 
distress, when controlling for initial differences at 
treatment intake. That is, both the PTSD and 
CPTSD groups had similar symptom trajectories 
in response to treatment. Further, the rate at 
which participants lost their provisional intake 
diagnoses at discharge was comparable for the 
CPTSD and PTSD groups. This suggests that 
while participants with CPTSD had more severe 
symptomatology overall, they were still able to 
engage and respond to the standard PTSD treat-
ment. This is consistent with findings from 
a recent meta-analysis which also suggested stan-
dard evidence-based trauma-focussed therapies for 
PTSD are likely to also be useful for those with 
CPTSD (Karatzias et al., 2019). Interestingly, in 
the current study, there was a moderate reduction 
in DSO symptoms from intake to discharge for 
those in the CPTSD group. While the pro-
grammes did not address DSO symptoms directly, 
these symptoms appear to have been at least par-
tially addressed indirectly through the individual 
and group-based symptom management and skills 
training for comorbid issues such as anxiety, 
anger and depression. It remains unclear whether 
or not the addition of intervention components 
that directly target DSO symptoms, such as emo-
tion regulation, negative self-concept and rela-
tionship disturbances, would further reduce post- 
treatment levels of PTSD symptom severity, psy-
chological distress and quality of life beyond the 
improvements seen with the current standard 
accredited PTSD treatment programmes.
It is noteworthy that by focusing on only partici-
pants who had a provisional ICD-11 PTSD or CPTSD 
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diagnosis, there were high numbers of participants in 
the accredited PTSD treatment programmes who 
were excluded from analysis – 63.6% of participants 
who had a DSM-5 PTSD diagnosis received 
a provisional ICD-11 PTSD or CPTSD diagnosis 
and were thus included in the current analyses. This 
suggests that the ICD-11 taxonomy captured 
a narrower group of participants than the DSM-5 
PTSD diagnosis, which is in line with previous stu-
dies that have demonstrated that ICD-11-based PTSD 
prevalence estimates are significantly lower than 
those derived from the DSM-5 (Wisco et al., 2016). 
This may mean that trauma-impacted people who 
might benefit from trauma-focussed therapy may be 
restricted from accessing appropriate trauma- 
focussed care and treatment if an ICD-11 diagnosis 
of PTSD or CPTSD is part of the eligibility criteria.
The findings of this study should be considered in 
the context of various limitations. First, the data were 
collected as part of routine quality assurance pro-
cesses for accredited PTSD treatment programmes, 
and there was no control condition. Given the lack 
of a control condition, these results do not preclude 
the possibility that observed symptom improvements 
were a reflection of natural fluctuations in the course 
of chronic PTSD. Second, while eligibility for the 
programmes was determined by a DSM-5 PTSD 
diagnosis as measured by the Clinician 
Administered PTSD Scale for DSM-5 (Weathers 
et al., 2018), the PCL-5 (Blevins et al., 2015) was 
used to determine a provisional diagnosis of ICD-11 
PTSD or CPTSD. Although items used as a proxy 
mapped onto the ICD-11 symptoms, it is possible 
that the available items did not fully capture the 
ICD-11 diagnostic construct, and the use of different 
measures may contribute to the notable drop in 
numbers from those eligible for the accredited 
PTSD treatment programmes to those eligible for 
this study. Third, although statistical models made 
use of all available data using multiple imputation, 
this technique provides unbiased estimates when data 
are missing at random (MAR), and there is no way to 
test whether this assumption holds in the current 
data. Fourth, while the Australian PTSD treatment 
programmes are independently assessed against 
accreditation standards that specify the components 
of treatment, these standards are broad so some het-
erogeneity in programmes content and delivery must 
be acknowledged.
Future research is required to help maximise 
treatment outcomes for current and ex-serving 
military members with CPTSD. The current study 
points to the high levels of clinical complexity of 
current and ex-serving military members present-
ing to standard PTSD programmes in Australia, 
and while participants respond to treatment with 
significant reductions in symptoms, those with 
CPTSD remain highly symptomatic. It is therefore 
essential to continue exploring how to enhance 
treatment outcomes in current and ex-serving mili-
tary members with CPTSD and maximise their 
end-state functioning. The ISTSS Guidelines 
Position Paper on CPTSD in Adults presents 
a number of future research directions to help 
identify optimal treatments for CPTSD 
(International Society of Traumatic Stress Studies, 
2018a). These include (i) comparing standard treat-
ments with protocols that add components target-
ing DSO symptoms, (ii) testing the order in which 
multi-component interventions are delivered, and 
(iii) examining the benefits of delivering multi- 
component treatments in flexible ways that target 
the most salient symptoms for a specific patient. 
Further research into these areas will ultimately 
assist current and ex-serving military personnel in 
their recovery from trauma.
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